Norway
· Delayed Price · Currency is NOK Hofseth BioCare ASA Statistics
Total Valuation
Hofseth BioCare ASA has a market cap or net worth of NOK 830.38 million. The enterprise value is 981.92 million.
| Market Cap | 830.38M |
| Enterprise Value | 981.92M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Hofseth BioCare ASA has 411.08 million shares outstanding. The number of shares has increased by 2.43% in one year.
| Shares Outstanding | 411.08M |
| Shares Change (YoY) | +2.43% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 18.62% |
| Owned by Institutions (%) | 35.91% |
| Float | 197.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.54 |
| PB Ratio | 6.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.10 |
| EV / Sales | 4.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -37.20 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 129.06.
| Current Ratio | 0.87 |
| Quick Ratio | 0.34 |
| Debt / Equity | 129.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.73 |
| Interest Coverage | -11.71 |
Financial Efficiency
Return on equity (ROE) is -95.34% and return on invested capital (ROIC) is -26.31%.
| Return on Equity (ROE) | -95.34% |
| Return on Assets (ROA) | -17.61% |
| Return on Capital (ROIC) | -26.31% |
| Revenue Per Employee | 3.29M |
| Profits Per Employee | -1.73M |
| Employee Count | 71 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.87% in the last 52 weeks. The beta is 0.37, so Hofseth BioCare ASA's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -35.87% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 47.97 |
| Average Volume (20 Days) | 78,594 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hofseth BioCare ASA had revenue of NOK 230.08 million and -121.18 million in losses. Loss per share was -0.30.
| Revenue | 230.08M |
| Gross Profit | 58.51M |
| Operating Income | -112.22M |
| Pretax Income | -121.18M |
| Net Income | -121.18M |
| EBITDA | -97.86M |
| EBIT | -112.22M |
| Loss Per Share | -0.30 |
Balance Sheet
The company has 25.30 million in cash and 177.52 million in debt, giving a net cash position of -152.22 million or -0.37 per share.
| Cash & Cash Equivalents | 25.30M |
| Total Debt | 177.52M |
| Net Cash | -152.22M |
| Net Cash Per Share | -0.37 |
| Equity (Book Value) | 137.55M |
| Book Value Per Share | 0.34 |
| Working Capital | -19.70M |
Cash Flow
In the last 12 months, operating cash flow was -19.24 million and capital expenditures -7.16 million, giving a free cash flow of -26.39 million.
| Operating Cash Flow | -19.24M |
| Capital Expenditures | -7.16M |
| Free Cash Flow | -26.39M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 25.43%, with operating and profit margins of -48.77% and -52.67%.
| Gross Margin | 25.43% |
| Operating Margin | -48.77% |
| Pretax Margin | -52.67% |
| Profit Margin | -52.67% |
| EBITDA Margin | -42.53% |
| EBIT Margin | -48.77% |
| FCF Margin | -11.47% |
Dividends & Yields
Hofseth BioCare ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.43% |
| Shareholder Yield | -2.43% |
| Earnings Yield | -14.89% |
| FCF Yield | -3.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |